The following is a summary of “Nonlinear association of cardiometabolic index with hyperuricemia: insights from the NHANES 1999-2018 study,” published in the March 2025 issue of Frontiers in ...

Summary. Febuxostat is a novel non-purine selective inhibitor of xanthine oxidase for the management of hyperuricemia in patients with gout. The ability of febuxostat to decrease serum uric acid ...

Hyperuricemia (HU) is a metabolic disorder characterized by elevated uric acid (UA) levels in the bloodstream, commonly diagnosed when UA levels ...

1 Hyperuricemia, elevated serum uric acid levels, can over time result in gout when urate crystals are deposited in joints and other body tissues, causing inflammatory responses and painful gout ...

Researchers from the University of the Philippines Manila have developed a gout medication made of ulasimang bato, also known as pansit-pansitan.

About Hyperuricemia and Gout In the US it is estimated that approximately 44 million individuals have circulating uric acid above the normal range (1). The prevalence of gout was 3.9% or 9.2 ...